'She added that the UK was at a “tipping point” in its relationship with the life sciences sector, which has been battling the government over taxes on drug prices, and what it says is a lack of investment in innovation. The number of industry clinical trials in the UK has fallen 41 per cent since 2017.'

https://www.ft.com/content/f20ae6ec-8207-4709-9bf9-99613c76980e